SAMHSA now accepting applications for next round of State Opioid Response funding
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On May 19, the White House announced the next round of State Opioid Response (SOR) grant funding opportunities through the Substance Abuse and Mental Health Services Administration (SAMHSA). This two-year funding opportunity provides nearly $1.5 billion in formula funds to states, territories and jurisdictions for prevention, treatment and recovery support services for opioid use disorders (OUD), and other concurrent substance use disorders (SUD).
The SOR grant program has awarded nearly $5.2 billion to local jurisdictions since it was first authorized under the 21st Century Cures Act (P.L. 114-255) in 2016. The program was reauthorized in the Fiscal Year (FY) 2020 appropriations bill, and again in the Consolidated Appropriations Act of 2022 (P.L. 117-103). States can apply by July 18, 2022 for funding to support projects up to two years in duration. The funding will be issued before September 30, 2022, and includes set-aside amounts for states with the highest OUD-related mortality rates.
Overdose deaths accelerated during the COVID-19 pandemic, with the most recent data from the Centers for Disease Control and Prevention (CDC) estimating that more than 105,000 people died from an overdose in the 12 months ending in October 2021, the highest number ever recorded in a 12-month period. As key administrators of behavioral health services, counties will continue to play an integral role in addressing the nation’s opioid crisis, working in partnership with states to use these and other federal funding sources to develop evidence-based programs that reduce overdose deaths, close the gap in treatment needs, and increase access to lifesaving medications and services in the communities where people need them most.
ADDITIONAL RESOURCES
Resource
Behavioral Health Matters to Counties
Related News
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.
Public-private partnership creates ‘one-stop shop’ to improve community wellness
The South Philadelphia Community Health and Literacy Center is a “one-stop shop” the city and the children’s hospital created to improve community wellness and make it easier for people to get their needs met.